Rockville-based RegenxBio Inc. has priced shares for its initial public offering, which could raise as much as $121 million.
RegenxBio will offer 5,555,555 shares of common stock, with a planned price range of $17 to $19 per share. Underwriters also have the option to buy an additional 833,333 shares.
{iframe}http://www.bizjournals.com/washington/blog/techflash/2015/09/we-now-know-how-much-regenxbio-could-raise-in-its.html?ana=e_du_pap&s=article_du&ed=2015-09-10&u=wjGEy67ABoSnsLErlc5ry0j5hx3&t=1441919280{/iframe}